<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <title>Funding</title>
 <p>The authors further acknowledge the support of this work by a grant from the IZKF (ACSP01) (S.D.E), the German Federal Institute for Risk Assessment (grant no. FKZ 1328-545), the Center for Sepsis Control and Care (Federal Ministry of Education and Research (BMBF), Germany, FKZ 01EO1502), InfectoGnostics Forschungscampus Jena (grant no 13GW0096D, ‘Innovative Diagnostik für Pneumonien bei Immunsuppression’) the Deutsche Forschungsgemeinschaft (LO 1618/6-1) and by internal funding from the Jena University Hospital. This work was financially supported by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence “Balance of the Microverse” under Germany’s Excellence Strategy – EXC 2051 – Project-ID 390713860 and by the European Commission through Marie Skłodowska-Curie Actions (MSCA) Innovative Training Network EUROoC (grant no. 812954) to A.S.M. the Collaborative Research Center PolyTarget 1278 from DFG project number 316213987 “Polymer-based nanoparticle libraries for targeted anti-inflammatory strategies” Project Z01 to M.T.F. Additionally, this work was supported by the Leibniz ScienceCampus InfectoOptics Jena, financed by the funding line Strategic Networking of the Leibniz Association (M.T.F.).</p>
</notes>
